Capabilities of the WinLTP Data Acquisition Program Extending Beyond Basic LTP Experimental Functions
Overview
Affiliations
WinLTP is a Windows data acquisition program designed for the investigation of long-term potentiation (LTP), long-term depression (LTD), and synaptic responses in general. The capabilities required for basic LTP and LTD experiments include alternating two-input extracellular pathway stimulation, LTP induction by single train, theta burst, and primed burst stimulation, and LTD induction by low frequency stimulation. WinLTP provides on-line analyses of synaptic waveforms including measurement of slope, peak amplitude, population-spike amplitude, average amplitude, area, rise time, decay time, duration, cell input resistance, and series resistance. WinLTP also has many advanced capabilities that extend beyond basic LTP experimental capabilities: (1) analysis of all the evoked synaptic potentials individually within a sweep, and the analysis of the entire train-evoked synaptic response as a single entity. (2) Multitasking can be used to run a Continuous Acquisition task (saving data to a gap-free Axon Binary File), while concurrently running the Stimulation/Acquisition Sweeps task. (3) Dynamic Protocol Scripting can be used to make more complicated protocols involving nested Loops (with counters), Delays, Sweeps (with various stimulations), and Run functions (which execute a block of functions). Protocol flow can be changed while the experiment is running. WinLTP runs on National Instruments M-Series and Molecular Devices Digidata 132x boards, and is available at www.winltp.com.
OKeeffe M, Booker S, Walsh D, Li M, Henley C, Simoes de Oliveira L Nat Neurosci. 2025; 28(2):268-279.
PMID: 39762658 PMC: 11802452. DOI: 10.1038/s41593-024-01833-x.
Siwiec M, Bobula B, Kielbinski M, Multan N, Hess G, Tokarski K Pharmacol Rep. 2024; 76(6):1377-1389.
PMID: 39487932 PMC: 11582198. DOI: 10.1007/s43440-024-00674-6.
Selective modulation of epileptic tissue by an adenosine A receptor-activating drug.
Ghosh A, Ribeiro-Rodrigues L, Ruffolo G, Alfano V, Domingos C, Rei N Br J Pharmacol. 2024; 181(24):5041-5061.
PMID: 39300608 PMC: 11578780. DOI: 10.1111/bph.17319.
Impact of Coffee Intake on Measures of Wellbeing in Mice.
Machado N, Ardais A, Nunes A, Szabo E, Silveirinha V, Silva H Nutrients. 2024; 16(17).
PMID: 39275237 PMC: 11396897. DOI: 10.3390/nu16172920.
Ruiz-Reig N, Chehade G, Yerna X, Dura I, Gailly P, Tissir F Front Neurosci. 2024; 18:1418973.
PMID: 39206115 PMC: 11349535. DOI: 10.3389/fnins.2024.1418973.